Vitaloni, Marianna http://orcid.org/0000-0002-4250-3525
Caccialanza, Riccardo http://orcid.org/0000-0002-9379-3569
Ravasco, Paula http://orcid.org/0000-0002-6056-8269
Carrato, Alfredo http://orcid.org/0000-0001-7749-8140
Kapala, Aleksandra http://orcid.org/0000-0003-4572-6641
de van der Schueren, Marian http://orcid.org/0000-0001-5693-0811
Constantinides, Dora
Backman, Eva
Chuter, David
Santangelo, Claudia
Maravic, Zorana http://orcid.org/0000-0001-6263-0313
Funding for this research was provided by:
Baxter International
AstraZeneca Schweiz
Novartis
Astellas Pharma Europe
Article History
Received: 8 March 2022
Accepted: 20 June 2022
First Online: 27 June 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Financial interests: Eva Backman, David Chuter, Dora Constantinides, Aleksandra Kapala, Zorana Maravic, Paula Ravasco, Claudia Santangelo, Marianna Vitaloni declare they have no financial or non-financial interests to disclose. Riccardo Caccialanza and Alfredo Carrato have received consultant honoraria from Baxter.
: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.